Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson long-term debt, noncurrent ($M) ($M)
Form 10-Q / 10-K Consolidated Balance Sheets
Latest, Q3 2026
35,799
Period ended Sep 30, 2026
Change on a year earlier
-9.2%
39,408 in Q3 2025
History
44 quarters
Since Q4 2015
Sources
38
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Long-term debt, noncurrent ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 35,799 | -9.2% | Form 10-Q (filed 2026-10-21) ↗ |
| Q2 2026 | Jun 28, 2026 | 37,344 | -4.8% | Form 10-Q (filed 2026-07-23) ↗ |
| Q1 2026 | Mar 29, 2026 | 37,527 | -2.2% | Form 10-Q (filed 2026-04-22) ↗ |
| Q4 2025 | Dec 28, 2025 | 39,438 | +28.7% | Form 10-Q (filed 2026-10-21) ↗ |
| Q3 2025 | Sep 28, 2025 | 39,408 | +25.9% | Form 10-Q (filed 2025-10-22) ↗ |
| Q2 2025 | Jun 29, 2025 | 39,235 | +24.0% | Form 10-Q (filed 2025-07-24) ↗ |
| Q1 2025 | Mar 30, 2025 | 38,355 | +52.9% | Form 10-Q (filed 2025-04-23) ↗ |
| Q4 2024 | Dec 29, 2024 | 30,651 | +18.4% | Form 10-K (filed 2026-02-11) ↗ |
| Q3 2024 | Sep 29, 2024 | 31,289 | +20.1% | Form 10-Q (filed 2024-10-23) ↗ |
| Q2 2024 | Jun 30, 2024 | 31,636 | -6.7% | Form 10-Q (filed 2024-07-25) ↗ |
| Q1 2024 | Mar 31, 2024 | 25,082 | -28.2% | Form 10-Q (filed 2024-05-01) ↗ |
| Q4 2023 | Dec 31, 2023 | 25,881 | -3.7% | Form 10-K (filed 2025-02-13) ↗ |
| Q3 2023 | Oct 1, 2023 | 26,051 | -5.6% | Form 10-Q (filed 2023-10-27) ↗ |
| Q2 2023 | Jul 2, 2023 | 33,901 | +19.8% | Form 10-Q (filed 2023-07-31) ↗ |
| Q1 2023 | Apr 2, 2023 | 34,928 | +21.1% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2022 | Jan 1, 2023 | 26,886 | -10.3% | Form 10-K (filed 2024-02-16) ↗ |
| Q3 2022 | Oct 2, 2022 | 27,603 | -8.4% | Form 10-Q (filed 2022-10-27) ↗ |
| Q2 2022 | Jul 3, 2022 | 28,292 | -6.7% | Form 10-Q (filed 2022-07-29) ↗ |
| Q1 2022 | Apr 3, 2022 | 28,851 | -4.7% | Form 10-Q (filed 2022-04-29) ↗ |
| Q4 2021 | Jan 2, 2022 | 29,985 | -8.1% | Form 10-K (filed 2023-02-16) ↗ |
| Q3 2021 | Oct 3, 2021 | 30,130 | -7.8% | Form 10-Q (filed 2021-10-29) ↗ |
| Q2 2021 | Jul 4, 2021 | 30,310 | +20.9% | Form 10-Q (filed 2021-07-29) ↗ |
| Q1 2021 | Apr 4, 2021 | 30,263 | +19.2% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Jan 3, 2021 | 32,635 | +23.2% | Form 10-K (filed 2022-02-17) ↗ |
| Q3 2020 | Sep 27, 2020 | 32,680 | +21.4% | Form 10-Q (filed 2020-10-23) ↗ |
| Q2 2020 | Jun 28, 2020 | 25,062 | -9.5% | Form 10-Q (filed 2020-07-24) ↗ |
| Q1 2020 | Mar 29, 2020 | 25,393 | -8.2% | Form 10-Q (filed 2020-04-29) ↗ |
| Q4 2019 | Dec 29, 2019 | 26,494 | -4.3% | Form 10-K (filed 2021-02-22) ↗ |
| Q3 2019 | Sep 29, 2019 | 26,919 | -8.7% | Form 10-Q (filed 2019-10-28) ↗ |
| Q2 2019 | Jun 30, 2019 | 27,699 | -5.8% | Form 10-Q (filed 2019-07-29) ↗ |
| Q1 2019 | Mar 31, 2019 | 27,660 | -7.3% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 30, 2018 | 27,684 | -9.8% | Form 10-Q (filed 2019-05-01) ↗ |
| Q3 2018 | Sep 30, 2018 | 29,480 | +10.5% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jul 1, 2018 | 29,405 | +7.5% | Form 10-Q (filed 2018-08-02) ↗ |
| Q1 2018 | Apr 1, 2018 | 29,837 | +10.4% | Form 10-Q (filed 2018-05-01) ↗ |
| Q4 2017 | Dec 31, 2017 | 30,675 | +36.7% | Form 10-K (filed 2019-02-20) ↗ |
| Q3 2017 | Oct 1, 2017 | 26,675 | +13.3% | 10-Q FY2017 (XBRL) ↗ |
| Q2 2017 | Jul 2, 2017 | 27,363 | +11.5% | 10-Q FY2017 (XBRL) ↗ |
| Q1 2017 | Apr 2, 2017 | 27,015 | +33.5% | 10-Q FY2017 (XBRL) ↗ |
| Q4 2016 | Jan 1, 2017 | 22,442 | +74.6% | Form 10-K (filed 2018-02-21) ↗ |
| Q3 2016 | Oct 2, 2016 | 23,546 | – | 10-Q FY2016 (XBRL) ↗ |
| Q2 2016 | Jul 3, 2016 | 24,535 | – | 10-Q FY2016 (XBRL) ↗ |
| Q1 2016 | Apr 3, 2016 | 20,233 | – | 10-Q FY2016 (XBRL) ↗ |
| Q4 2015 | Jan 3, 2016 | 12,857 | – | 10-K FY2015 (XBRL) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson Long-term debt, noncurrent ($M) ($M), quarterly Q4 2015–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/lt_debt_nc_bs
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.